摘要
本文通过分析FDA等药品监管机构公开的药品说明书和评价报告等信息,总结具有代表性的已上市抗2型糖尿病药物的生殖毒性信息和安全性范围,为2型糖尿病药物的非临床安全性评价和临床生殖毒性风险控制措施的制订提供参考。
The aim of this review is to provide reference information for the non-clinical safety evaluation and reproductive toxicity risk management in clinical tirals for anti-diabetic agents.The reproductive and developmental toxicity information as well as the safety ranges of the representative anti-diabetic agents for type 2 diabetes mellitus on the market were summarized based on the labeling and review documents obtained from the official website of the US Food and Drug Administration and other regulatory agencies.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2017年第23期2772-2779,共8页
Chinese Journal of New Drugs
关键词
2型糖尿病治疗药物
生殖毒性
安全范围
风险控制
anti-diabetic agents for type 2 diabetes mellitus (T2DM)
reproductive and developmentaltoxicity
safety range
risk management